2 completed, 1 recruiting, 1 unknown. 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Blood Brain Barrier: new trials by email Literature Review of Blood Brain Barrier trials Research Report on Blood Brain Barrier
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Clinical Trial to Assess the Safety of NMS-01 in Patients With Mild to Moderate Alzheimer's Disease NMS-01 - Alzheimer's Disease, Blood Brain Barrier | Not applicable | Recruiting | Neumous Inc. | 10 | 2026-01-05 | 2026-10-09 |
| Understanding How Gut and Brain Barriers Are Linked to Inflammation in Obesity Obesity (Disorder), Systemic Inflammation Markers | Completed | University Hospital, Gentofte, Copenhagen | 50 | 2025-04-01 | 2026-02-18 | |
| Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke Cerebrolysin, Brain-MRI with contrast after 10-14 days of cerebrolysin - Ischemic Stroke, Acute, Diabetes Mellitus, Type 2 | Phase 4 | Unknown | Hospital Universitario Dr. Jose E. Gonzalez | 60 | 2022-11-17 | 2024-02-22 |
| The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease Contrast agent enhanced MRI using Gadovist - Blood Brain Barrier, Alzheimer Disease | Completed | Charite University, Berlin, Germany | 101 | 2019-09-12 | 2021-11-11 |
Alzheimer Disease (2) · Cognitive Dysfunction (1) · Dementia (1) · Diabetes Mellitus, Type 2 (1) · Ischemic Stroke (1) · Neurodegenerative Diseases (1) · Obesity (1) · Stroke (1)
Nervous System Diseases (4) · Brain Diseases (3) · Central Nervous System Diseases (3) · Mental Disorders (2) · Neurocognitive Disorders (2) · Neurodegenerative Diseases (2) · Nutritional and Metabolic Diseases (2) · Tauopathies (2) · Body Weight (1) · Cardiovascular Diseases (1) · Cerebrovascular Disorders (1) · Cognition Disorders (1) · Dementia (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1)
cerebrolysin (1)
Charite University, Berlin, Germany (1) · Hospital Universitario Dr. Jose E. Gonzalez (1) · Neumous Inc. (1) · University Hospital, Gentofte, Copenhagen (1)
Denmark (1) · Germany (1) · Mexico (1) · South Korea (1)